Elanco Animal Health Inc - COMMON STOCK (ELAN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
ELAN on NYSE
Shares outstanding
492,937,031
Price per share
$22.63
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
570,853,239
Total reported value
$11,496,483,666
% of total 13F portfolios
0.01%
Share change
+32,508,916
Value change
+$680,251,265
Number of holders
402
Price from insider filings
$22.63
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elanco Animal Health Inc - COMMON STOCK (ELAN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 13% +31% $975,846,299 +$230,747,801 64,883,398 +31% FMR LLC 30 Jun 2025
BlackRock, Inc. 8.9% +112% $886,598,367 +$443,042,097 44,021,766 +100% BlackRock, Inc. 30 Sep 2025
T. Rowe Price Investment Management, Inc. 6.4% $635,376,116 31,547,970 T. Rowe Price Investment Management, Inc. 30 Sep 2025

As of 30 Sep 2025, 402 institutional investors reported holding 570,853,239 shares of Elanco Animal Health Inc - COMMON STOCK (ELAN). This represents 116% of the company’s total 492,937,031 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Elanco Animal Health Inc - COMMON STOCK (ELAN) together control 98% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Dodge & Cox 17% 82,759,837 -0.16% 0.9% $1,666,783,117
FMR LLC 13% 65,357,380 +0.73% 0.07% $1,316,297,631
PRIMECAP MANAGEMENT CO/CA/ 10% 49,958,156 -3.5% 0.77% $1,006,157,262
VANGUARD GROUP INC 9.9% 48,586,708 +1.6% 0.01% $978,536,298
BlackRock, Inc. 9.4% 46,178,502 +100% 0.02% $930,035,025
T. Rowe Price Investment Management, Inc. 6.4% 31,510,014 +61% 0.39% $634,612,000
DIMENSIONAL FUND ADVISORS LP 5% 24,708,676 +8.6% 0.11% $497,609,839
UBS Group AG 3.3% 16,468,148 +57% 0.06% $331,668,501
STATE STREET CORP 3.1% 15,245,783 +67% 0.01% $307,050,070
Black Creek Investment Management Inc. 2.5% 12,482,461 -35% 12% $251,396,765
MORGAN STANLEY 2.1% 10,265,905 +2.9% 0.01% $206,755,378
GEODE CAPITAL MANAGEMENT, LLC 1.8% 8,785,435 +8.9% 0.01% $176,973,060
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1.5% 7,583,575 +26% 0.13% $152,733,201
Nuveen, LLC 1.4% 7,083,854 -14% 0.04% $142,668,820
SHAPIRO CAPITAL MANAGEMENT LLC 1.3% 6,396,549 -31% 5.6% $128,826,497
BRANDES INVESTMENT PARTNERS, LP 1.2% 5,939,517 -27% 0.96% $119,621,872
Clearbridge Investments, LLC 1.2% 5,897,598 +9.3% 0.09% $118,777,626
MILLENNIUM MANAGEMENT LLC 1.1% 5,612,831 +46% 0.09% $113,042,416
Bank of New York Mellon Corp 1% 5,131,116 +190% 0.02% $103,340,670
BARROW HANLEY MEWHINNEY & STRAUSS LLC 1% 5,036,147 -34% 0.32% $101,428,001
FULLER & THALER ASSET MANAGEMENT, INC. 1% 4,971,877 -2.6% 0.34% $100,133,610
CITADEL ADVISORS LLC 0.98% 4,843,380 -65% 0.08% $97,545,673
NORTHERN TRUST CORP 0.87% 4,291,618 +48% 0.01% $86,433,186
JENNISON ASSOCIATES LLC 0.81% 3,974,347 +23% 0.05% $80,043,348
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.8% 3,919,139 -8.4% 0.01% $78,931,459

Institutional Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,606,331 $36,383,749 +$620,093 $22.63 43
2025 Q3 570,853,239 $11,496,483,666 +$680,251,265 $20.14 402
2025 Q2 538,352,937 $7,687,668,693 +$655,647,979 $14.28 362
2025 Q1 494,022,445 $5,187,492,485 +$2,004,620 $10.50 359
2024 Q4 489,345,019 $5,925,862,528 +$26,438,350 $12.11 387
2024 Q3 481,862,274 $7,076,192,785 -$28,345,131 $14.69 384
2024 Q2 482,171,600 $6,957,441,182 +$6,686,922 $14.43 396
2024 Q1 480,177,163 $7,816,997,297 +$26,389,803 $16.28 370
2023 Q4 479,962,841 $7,151,250,374 +$21,579,978 $14.90 349
2023 Q3 481,442,000 $5,409,895,330 +$102,163,765 $11.24 344
2023 Q2 473,375,354 $4,760,610,377 -$67,531,728 $10.06 345
2023 Q1 479,522,703 $4,495,944,050 -$110,942,259 $9.40 384
2022 Q4 481,681,648 $5,908,155,843 +$232,156,887 $12.22 398
2022 Q3 463,043,345 $5,755,609,685 -$196,296,127 $12.41 398
2022 Q2 470,431,046 $9,236,728,928 -$88,523,747 $19.63 421
2022 Q1 473,375,688 $12,362,622,405 -$47,241,309 $26.09 454
2021 Q4 475,123,500 $13,465,426,403 +$218,382,206 $28.38 461
2021 Q3 467,401,656 $14,907,014,269 -$71,757,204 $31.89 435
2021 Q2 468,283,929 $16,250,367,215 +$128,764,524 $34.69 464
2021 Q1 467,015,636 $13,752,652,796 +$242,000,095 $29.45 433
2020 Q4 458,146,787 $14,050,001,284 +$1,375,218,703 $30.67 424
2020 Q3 413,516,389 $11,539,620,540 +$535,290,448 $27.93 348
2020 Q2 396,250,140 $8,506,918,630 -$172,335,832 $21.45 355
2020 Q1 402,762,228 $9,017,316,731 +$571,966,377 $22.39 350
2019 Q4 369,452,160 $10,879,469,608 -$57,025,660 $29.45 390
2019 Q3 371,517,866 $9,877,782,405 -$152,630,501 $26.59 359
2019 Q2 374,935,481 $12,675,665,904 +$446,834,964 $33.80 364
2019 Q1 373,768,060 $11,987,183,816 +$9,247,514,461 $32.07 342
2018 Q4 85,024,329 $2,681,019,350 +$393,741,056 $31.53 164
2018 Q3 71,099,284 $2,480,509,428 +$2,480,239,432 $34.89 153
2016 Q2 0 $0 -$6,000 $22.63 0
2016 Q1 186 $6,000 $32.26 1